Kristel Van Laethem
AuthID: R-006-TPJ
61
TÃTULO: Drug resistance among therapy-naive HIV-infected patients studied by sequencing and VERSANT (TM) HIV-1 resistance assays (LiPA) has limited impact on treatment response.
AUTORES: Derdelinckx, I; Van Laethem, K; Maes, B; Schrooten, Y; Dewit, S; Florence, E; Fransen, K; Ribas, SG; Marissens, D; Moutschen, M; Van Wijngaerden, E; Vaira, D; Zissis, G; Van Ranst, M; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
AUTORES: Derdelinckx, I; Van Laethem, K; Maes, B; Schrooten, Y; Dewit, S; Florence, E; Fransen, K; Ribas, SG; Marissens, D; Moutschen, M; Van Wijngaerden, E; Vaira, D; Zissis, G; Van Ranst, M; Vandamme, AM;
PUBLICAÇÃO: 2002, FONTE: ANTIVIRAL THERAPY, VOLUME: 7
INDEXADO EM: 
WOS
WOS62
TÃTULO: A new phenotypic assay to evaluate HIV susceptibility towards entry inhibitors
AUTORES: Fikkert, V; Cherepanov, P; Van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLICAÇÃO: 2002, FONTE: 14th International AIDS Conference in XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE
AUTORES: Fikkert, V; Cherepanov, P; Van Laethem, K; Hantson, A; Van Remoortel, B; Pannecouque, C; De Clercq, E; Debyser, Z; Vandamme, AM; Witvrouw, M;
PUBLICAÇÃO: 2002, FONTE: 14th International AIDS Conference in XIV INTERNATIONAL AIDS CONFERENCE: CLINICAL SCIENCES AND CARE
INDEXADO EM: WOS
WOS63
TÃTULO: Mutations in the non-nucleoside binding-pocket interfere with the multi-nucleoside resistance phenotype
AUTORES: Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Schmit, JC; Esnouf, R; Kleim, JP; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2001, FONTE: AIDS, VOLUME: 15, NÚMERO: 5
AUTORES: Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Schmit, JC; Esnouf, R; Kleim, JP; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2001, FONTE: AIDS, VOLUME: 15, NÚMERO: 5
64
TÃTULO: Prevalence and characteristics of multinucleoside-resistant human immunodeficiency virus type 1 among European patients receiving combinations of nucleoside analogues
AUTORES: Van Vaerenbergh, K; Van Laethem, K; Albert, J; Boucher, CAB; Clotet, B; Floridia, M; Gerstoft, J; Hejdeman, B; Nielsen, C; Pannecouque, C; Perrin, L; Pirillo, MF; Ruiz, L; Schmit, JC; Schneider, F; Schoolmeester, A; Schuurman, R; Stellbrink, HJ; Stuyver, L; Van Lunzen, J; ...Mais
PUBLICAÇÃO: 2000, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 44, NÚMERO: 8
AUTORES: Van Vaerenbergh, K; Van Laethem, K; Albert, J; Boucher, CAB; Clotet, B; Floridia, M; Gerstoft, J; Hejdeman, B; Nielsen, C; Pannecouque, C; Perrin, L; Pirillo, MF; Ruiz, L; Schmit, JC; Schneider, F; Schoolmeester, A; Schuurman, R; Stellbrink, HJ; Stuyver, L; Van Lunzen, J; ...Mais
PUBLICAÇÃO: 2000, FONTE: ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, VOLUME: 44, NÚMERO: 8
65
TÃTULO: Patient HIV-1 strains carrying the multiple nucleoside resistance mutations are cross-resistant to abacavir
AUTORES: Van Laethem, K; Witvrouw, M; Balzarini, J; Schmit, JC; Sprecher, S; Hermans, P; Leal, M; Harrer, T; Ruiz, L; Clotet, B; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS, VOLUME: 14, NÚMERO: 4
AUTORES: Van Laethem, K; Witvrouw, M; Balzarini, J; Schmit, JC; Sprecher, S; Hermans, P; Leal, M; Harrer, T; Ruiz, L; Clotet, B; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS, VOLUME: 14, NÚMERO: 4
66
TÃTULO: Baseline HIV type 1 genotypic resistance to a newly added nucleoside analog is predictive of virologic failure of the new therapy
AUTORES: Van Vaerenbergh, K; Van Laethem, K; Van Wijngaerden, E; Schmit, JC; Schneider, F; Ruiz, L; Clotet, B; Verhofstede, C; Van Wanzeele, F; Muyldermans, G; Simons, P; Stuyver, L; Hermans, P; Evans, C; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 16, NÚMERO: 6
AUTORES: Van Vaerenbergh, K; Van Laethem, K; Van Wijngaerden, E; Schmit, JC; Schneider, F; Ruiz, L; Clotet, B; Verhofstede, C; Van Wanzeele, F; Muyldermans, G; Simons, P; Stuyver, L; Hermans, P; Evans, C; De Clercq, E; Desmyter, J; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 16, NÚMERO: 6
67
TÃTULO: Presence of 2 ',5 '-bis-O-(tert-butyldimethylsilyl)-3 '-spiro-5 ''-(4 ''-amino-1 '',2 ''-oxathiole-2 '',2 ''-dioxide) (TSAO)-resistant virus strains in TSAO-inexperienced HIV patients
AUTORES: Van Laethem, K; Schmit, JC; Pelemans, H; Balzarini, J; Witvrouw, M; Perez Perez, MJ; Camarasa, MJ; Esnouf, RM; Aquaro, S; Cenci, A; Perno, CF; Hermans, P; Sprecher, S; Ruiz, L; Clotet, B; Van Wijngaerden, E; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 16, NÚMERO: 9
AUTORES: Van Laethem, K; Schmit, JC; Pelemans, H; Balzarini, J; Witvrouw, M; Perez Perez, MJ; Camarasa, MJ; Esnouf, RM; Aquaro, S; Cenci, A; Perno, CF; Hermans, P; Sprecher, S; Ruiz, L; Clotet, B; Van Wijngaerden, E; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS RESEARCH AND HUMAN RETROVIRUSES, VOLUME: 16, NÚMERO: 9
68
TÃTULO: Phenotypic multi-nucleoside resistance linked to the Q151M mutation is enhanced under the selective pressure of acyclic nucleotide analogs but reduced by foscarnet
AUTORES: Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Esnouf, R; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS, VOLUME: 14
AUTORES: Van Laethem, K; Witvrouw, M; Pannecouque, C; Van Remoortel, B; Esnouf, R; Balzarini, J; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 2000, FONTE: AIDS, VOLUME: 14
INDEXADO EM: WOS
WOS69
TÃTULO: Phenotypic assays and sequencing are less sensitive than point mutation assays for detection of resistance in mixed HIV-1 genotypic populations
AUTORES: Van Laethem, K; Van Vaerenbergh, K; Schmit, JC; Sprecher, S; Hermans, P; De Vroey, V; Schuurman, R; Harrer, T; Witvrouw, M; Van Wijngaerden, E; Stuyver, L; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 1999, FONTE: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 22, NÚMERO: 2
AUTORES: Van Laethem, K; Van Vaerenbergh, K; Schmit, JC; Sprecher, S; Hermans, P; De Vroey, V; Schuurman, R; Harrer, T; Witvrouw, M; Van Wijngaerden, E; Stuyver, L; Van Ranst, M; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 1999, FONTE: JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, VOLUME: 22, NÚMERO: 2
INDEXADO EM: 
Scopus WOS
Scopus WOS70
TÃTULO: Activity of non-nucleoside reverse transcriptase inhibitors against HIV-2 and SIV
AUTORES: Witvrouw, M; Pannecouque, C; Van Laethem, K; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 1999, FONTE: AIDS, VOLUME: 13, NÚMERO: 12
AUTORES: Witvrouw, M; Pannecouque, C; Van Laethem, K; Desmyter, J; De Clercq, E; Vandamme, AM;
PUBLICAÇÃO: 1999, FONTE: AIDS, VOLUME: 13, NÚMERO: 12
